These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2168225)

  • 1. Sulfation of tyrosine residues in coagulation factor V.
    Hortin GL
    Blood; 1990 Sep; 76(5):946-52. PubMed ID: 2168225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity.
    Pittman DD; Tomkinson KN; Michnick D; Selighsohn U; Kaufman RJ
    Biochemistry; 1994 Jun; 33(22):6952-9. PubMed ID: 8204629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.
    Pittman DD; Wang JH; Kaufman RJ
    Biochemistry; 1992 Apr; 31(13):3315-25. PubMed ID: 1554716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
    Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
    J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine sulfation in precursors of collagen V.
    Fessler LI; Brosh S; Chapin S; Fessler JH
    J Biol Chem; 1986 Apr; 261(11):5034-40. PubMed ID: 3082875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line.
    Wilson DB; Salem HH; Mruk JS; Maruyama I; Majerus PW
    J Clin Invest; 1984 Mar; 73(3):654-8. PubMed ID: 6200498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII.
    Ofosu FA
    Haemostasis; 1991; 21(4):240-7. PubMed ID: 1794749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular changes associated with proteolysis of bovine factor V by thrombin.
    Kandall CL; Rosenberg R; Colman RW
    Eur J Biochem; 1975 Oct; 58(1):203-11. PubMed ID: 1183435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII.
    Bukys MA; Orban T; Kim PY; Beck DO; Nesheim ME; Kalafatis M
    J Biol Chem; 2006 Jul; 281(27):18569-80. PubMed ID: 16624813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.
    Gerads I; Tans G; Yukelson LYa ; Zwaal RF; Rosing J
    Toxicon; 1992 Sep; 30(9):1065-79. PubMed ID: 1440644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorate-induced inhibition of tyrosine sulfation on bone sialoprotein synthesized by a rat osteoblast-like cell line (UMR 106-01 BSP).
    Mintz KP; Fisher LW; Grzesik WJ; Hascall VC; Midura RJ
    J Biol Chem; 1994 Feb; 269(7):4845-52. PubMed ID: 8106456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B
    J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of human coagulation factor V.
    Kane WH; Majerus PW
    J Biol Chem; 1981 Jan; 256(2):1002-7. PubMed ID: 7451453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfation of two tyrosine-residues in human complement S-protein (vitronectin).
    Jenne D; Hille A; Stanley KK; Huttner WB
    Eur J Biochem; 1989 Nov; 185(2):391-5. PubMed ID: 2479556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine sulfation of proteins from the human hepatoma cell line HepG2.
    Liu MC; Yu S; Sy J; Redman CM; Lipmann F
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7160-4. PubMed ID: 2414772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
    Dharmawardana KR; Bock PE
    Biochemistry; 1998 Sep; 37(38):13143-52. PubMed ID: 9748321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.
    Samis JA; Garrett M; Manuel RP; Nesheim ME; Giles AR
    Blood; 1997 Aug; 90(3):1065-74. PubMed ID: 9242537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma.
    Pieters J; Lindhout T; Hemker HC
    Blood; 1989 Aug; 74(3):1021-4. PubMed ID: 2502206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo sulfation of L-tyrosine in HepG2 human hepatoma cells and its possible functional implication.
    Sakakibara Y; Suiko M; Liu MC
    Eur J Biochem; 1994 Dec; 226(2):293-301. PubMed ID: 8001547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid residues 721-729 are required for full factor VIII activity.
    Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
    Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.